Kinnate Biopharma Stock Technical Analysis

KNTEDelisted Stock  USD 2.96  0.27  8.36%   
As of the 28th of December, Kinnate Biopharma secures the Standard Deviation of 5.59, risk adjusted performance of 0.0044, and Mean Deviation of 4.52. Kinnate Biopharma technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Kinnate Biopharma information ratio and potential upside to decide if Kinnate Biopharma is priced some-what accurately, providing market reflects its recent price of 2.96 per share. Please also check out Kinnate Biopharma jensen alpha, which is currently at (0.09) to check the company can sustain itself at a future point.

Kinnate Biopharma Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Kinnate, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Kinnate
  
Kinnate Biopharma's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.
Kinnate Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Kinnate Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Kinnate Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Kinnate Biopharma Technical Analysis

Indicator
Time Period
Execute Indicator
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

Kinnate Biopharma Trend Analysis

Use this graph to draw trend lines for Kinnate Biopharma. You can use it to identify possible trend reversals for Kinnate Biopharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Kinnate Biopharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Kinnate Biopharma Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Kinnate Biopharma applied against its price change over selected period. The best fit line has a slop of   0.0052  , which may suggest that Kinnate Biopharma market price will keep on failing further. It has 122 observation points and a regression sum of squares at 1.04, which is the sum of squared deviations for the predicted Kinnate Biopharma price change compared to its average price change.

About Kinnate Biopharma Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Kinnate Biopharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Kinnate Biopharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Kinnate Biopharma price pattern first instead of the macroeconomic environment surrounding Kinnate Biopharma. By analyzing Kinnate Biopharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Kinnate Biopharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Kinnate Biopharma specific price patterns or momentum indicators. Please read more on our technical analysis page.

Kinnate Biopharma December 28, 2024 Technical Indicators

Most technical analysis of Kinnate help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Kinnate from various momentum indicators to cycle indicators. When you analyze Kinnate charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Consideration for investing in Kinnate Stock

If you are still planning to invest in Kinnate Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kinnate Biopharma's history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities